ABN AMRO Bank N.V. Purchases New Stake in Danaher Corporation $DHR

ABN AMRO Bank N.V. purchased a new stake in shares of Danaher Corporation (NYSE:DHR) during the third quarter, HoldingsChannel reports. The institutional investor purchased 37,877 shares of the conglomerate’s stock, valued at approximately $7,266,000.

Other large investors also recently made changes to their positions in the company. Sivia Capital Partners LLC boosted its position in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares during the period. Merit Financial Group LLC lifted its stake in shares of Danaher by 17.5% during the second quarter. Merit Financial Group LLC now owns 17,099 shares of the conglomerate’s stock worth $3,378,000 after purchasing an additional 2,544 shares in the last quarter. BankPlus Trust Department boosted its position in shares of Danaher by 6.1% in the second quarter. BankPlus Trust Department now owns 3,575 shares of the conglomerate’s stock worth $706,000 after buying an additional 207 shares during the period. Venturi Wealth Management LLC grew its stake in shares of Danaher by 1,901.9% in the second quarter. Venturi Wealth Management LLC now owns 66,764 shares of the conglomerate’s stock valued at $13,189,000 after buying an additional 63,429 shares in the last quarter. Finally, REAP Financial Group LLC raised its holdings in shares of Danaher by 197.3% during the 2nd quarter. REAP Financial Group LLC now owns 440 shares of the conglomerate’s stock valued at $87,000 after buying an additional 292 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. This trade represents a 66.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 30,248 shares of company stock worth $6,609,663 in the last ninety days. 11.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Guggenheim upped their price target on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 2nd. JPMorgan Chase & Co. upped their target price on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Evercore ISI reissued an “outperform” rating and issued a $254.00 price objective on shares of Danaher in a research report on Wednesday, January 28th. Finally, HSBC boosted their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, December 1st. Twenty investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $252.32.

Danaher Stock Up 1.3%

Shares of Danaher stock opened at $219.31 on Thursday. The business has a 50-day moving average price of $230.07 and a 200 day moving average price of $214.68. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The firm has a market cap of $154.91 billion, a P/E ratio of 43.51, a P/E/G ratio of 2.93 and a beta of 0.91. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. During the same quarter in the previous year, the company posted $2.14 earnings per share. The firm’s revenue was up 4.6% on a year-over-year basis. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were given a dividend of $0.32 per share. The ex-dividend date was Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is currently 25.40%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.